NC lawmakers failed to expand Medicaid again, this time amid COVID. Now, even more people will suffer. (Letters to the Editor)
A five-day treatment of remdesivir will cost $3,120 for a typical U.S. patient with commercial insurance. Gilead Sciences, the drugmaker, has promised a lower “government price,” but that excludes Medicare and Medicaid. @ShoshUMD joins CBSN to discuss the potential impact
Proud of all the Americans who showed up to vote yesterday, electing a set of hopeful, forward-thinking leaders primed to protect Medicaid, draw fair voting maps, and reduce gun violence. A great night for our country—one that’ll leave a lasting legacy.
Seriously. This is BANANAS. You couldn't get ALL 50 state Medicaid directors to agree any anything else in health care policy.